EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
2 05-2024

EBC at the 36th Global Conference of Alzheimer’s Disease International

2024-05-03T08:34:26+00:0002-05-2024|News|

The 36th Global Conference of Alzheimer’s Disease International (ADI) took place in Kraków, Poland from 24-26 April 2024, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). Held under the overarching theme of "Dementia: Insights. Innovations. Inspirations.", the conference brought together more than 1000 delegates from over 100 countries to share [...]

9 10-2023

Look back at the highlights of the Rethinking Alzheimer’s disease virtual event

2023-10-09T09:28:30+00:0009-10-2023|News|

Alzheimer's disease, the most common form of dementia, is a pressing issue for our lifetime. Society needs to be responsive to ensure that people can live with more dignity and access services and resources despite their diagnosis. On 26 September 2023, the European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical [...]

14 03-2023

EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper

2023-04-03T14:57:28+00:0014-03-2023|News|

On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) launch the RETHINKING Alzheimer's disease White Paper, calling for change in the detection and diagnosis of Alzheimer's disease. About Alzheimer's disease Alzheimer’s disease (AD), the most common form of [...]

24 01-2023

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch

2023-03-30T09:01:01+00:0024-01-2023|News|

Every three seconds someone develops dementia and for most of these individuals this will be as a result of Alzheimer’s disease, the leading cause. Alzheimer's is a relentless neurodegenerative condition which robs people of their memories, their independence, their relationships, and ultimately, their lives. On 24 January 2023, the European Brain Council (EBC), in collaboration [...]

8 12-2022

Registration now open for the launch event of the RETHINKING Alzheimer’s disease White Paper

2023-01-10T12:03:16+00:0008-12-2022|News|

Registration is now open for the launch event of the RETHINKING Alzheimer's disease White Paper, taking place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper [...]

26 10-2022

Alzheimer Europe Conference: Symposium on rethinking the early detection and diagnosis of Alzheimer’s disease

2023-02-06T12:34:26+00:0026-10-2022|News|

Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health needs. It represents between 60% and 70% of the dementia cases. It is still diagnosed too late when the symptoms become evident as the disease progresses.  AD is now portrayed as continuum consisting of 3 stages: [...]

Go to Top